AXNX — Axonics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge Cap

Annual balance sheet for Axonics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	184	241	221	357	345
Net Total Accounts Receivable
Net Total Receivables	7.88	18.3	29	44.8	57.2
Total Inventory
Prepaid Expenses
Total Current Assets	212	328	321	465	491
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.25	13.4	14	13	33.3
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	220	342	548	659	720
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12	45.7	26.9	65.2	45.8
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	36.8	54.8	65.5	89.2	82.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	183	287	482	570	638
Total Liabilities & Shareholders' Equity	220	342	548	659	720
Total Common Shares Outstanding